{"SLR NAME":"Prevalence and impact of cardiac injury in patients with COVID-19","References":[{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases."},{"title3":"Aging."},{"title3":"Aging and innate immune cells."},{"title3":"The role of immunity in susceptibility to respiratory infection in the aging lung."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Severe acute respiratory syndrome."},{"title3":"An interferon-gamma-related cytokine storm in SARS patients."},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome."},{"title3":"The acute respiratory distress syndrome."},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children."},{"title3":"Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children."},{"title3":"Severe acute respiratory syndrome in children."},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome."},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus."},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome."},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome."},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis."},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells."},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques."},{"title3":"Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design."},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus."},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Transcriptional mechanisms of acute lung injury."},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury."},{"title3":"A global test for groups of genes: testing association with a clinical outcome."},{"title3":"Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms."},{"title3":"Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits."},{"title3":"Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses."},{"title3":"Acetylation of Stat1 modulates NF-kappaB activity."},{"title3":"Pathogen recognition and innate immunity."},{"title3":"The interleukin 1 receptor: ligand interactions and signal transduction."},{"title3":"Nonhuman primate models for SARS."},{"title3":"The molecular inflammatory process in aging."},{"title3":"Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation."},{"title3":"IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice."},{"title3":"Immunosenescence: emerging challenges for an ageing population."},{"title3":"Aging and proinflammatory cytokines."},{"title3":"Inflamm-aging. An evolutionary perspective on immunosenescence."},{"title3":"The membrane protein of SARS-CoV suppresses NF-kappaB activation."},{"title3":"SARS coronavirus and innate immunity."},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists."},{"title3":"Genomic Analysis Reveals Age Dependent Innate Immune Responses to SARS Coronavirus."},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection."},{"title3":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon."},{"title3":"Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly."},{"title3":"Altered cytokine production in the elderly."},{"title3":"Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT."},{"title3":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system."},{"title3":"Suppression of experimental allergic encephalomyelitis by interferon."},{"title3":"Anti-inflammatory properties of Type I interferons."},{"title3":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice."},{"title3":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis."},{"title3":"Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells."},{"title3":"When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction."},{"title3":"TAM receptors are pleiotropic inhibitors of the innate immune response."},{"title3":"Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes."},{"title3":"Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions."},{"title3":"Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression."},{"title3":"NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity."},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice."},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study."},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method."},{"title3":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression."},{"title3":"Some thoughts on clinical trials, especially problems of multiplicity."},{"title3":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments."},{"title3":"Controlling the false discovery rate: a practical and powerful approach to multiple testing."}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015"},{"title3":"Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"The art of modeling the mortality impact of winter-seasonal pathogens"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Influenza associated mortality in the subtropics and tropics: results from three Asian cities"},{"title3":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong"},{"title3":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010"},{"title3":"Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic"},{"title3":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Surveillance of antibiotic resistance"},{"title3":"The computation of equivalent potential temperature"},{"title3":"Third universal definition of myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Triggering of acute myocardial infarction by respiratory infection"},{"title3":"Acute cardiac injury events &lt;/=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012"},{"title3":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction"},{"title3":"Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies"},{"title3":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction"},{"title3":"Influenza vaccines for preventing cardiovascular disease"},{"title3":"A matched influenza vaccine strain was effective in reducing the risk of acute myocardial infarction in elderly persons: a population-based study"},{"title3":"Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects"},{"title3":"The causes and diagnosis of influenza-like illness"},{"title3":"Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change"},{"title3":"Relationship between supra-annual trends in influenza rates and stroke occurrence"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza"},{"title3":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection"},{"title3":"Influenza vaccination is associated with a reduced risk of stroke"},{"title3":"Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: a population-based cohort study"},{"title3":"Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke"},{"title3":"Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection"},{"title3":"Model selection in time series studies of influenza-associated mortality"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"},{"title3":"Cardiovascular disease as a complication of community-acquired pneumonia"},{"title3":"Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)"},{"title3":"Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"World Health Organization (2004) Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/. Cited 8 May 2004"},{"title3":"SARS: responding to an unknown virus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Profile of specific antibodies to the SARS-associated coronavirus"},{"title3":"Serology of severe acute respiratory syndrome: implications for surveillance and outcome"},{"title3":"SARS-CoV antibody prevalence in all Hong Kong patient contacts"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus"},{"title3":"World Health Organization (2003) PCR primers for SARS developed by WHO network laboratories [monograph on the Internet]. Available at: http://www.who.int/csr/sars/primers/en/. Cited 20 April 2003"},{"title3":"Epidemiological features of severe acute respiratory syndrome in Beijing"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection"},{"title3":"Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus"},{"title3":"Genetic variation of SARS coronavirus in Beijing hospital"},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital"},{"title3":"Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan"},{"title3":"SARS-associated coronavirus quasispeies in individual patients"},{"title3":"Isolation and identification of SARS-CoV from stool of SARS patients in different phase of disease"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series"},{"title3":"Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016"},{"title3":"Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017"},{"title3":"Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017"},{"title3":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017"},{"title3":"Novel influenza A viruses and pandemic threats"},{"title3":"Pathogenesis of influenza-induced acute respiratory distress syndrome"},{"title3":"Influenza virus-induced lung injury: pathogenesis and implications for treatment"},{"title3":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"},{"title3":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study"},{"title3":"Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age"},{"title3":"Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A (H7N9) virus"},{"title3":"Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Corticosteroid therapy for critically ill patients with the middle east respiratory syndrome"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"H5N1 infection of the respiratory tract and beyond: a molecular pathology study"},{"title3":"The role of adjuvant immunomodulatory agents for treatment of severe influenza"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance"},{"title3":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China"},{"title3":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics"},{"title3":"Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir"},{"title3":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations"},{"title3":"Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study"},{"title3":"Antiviral combinations for severe influenza"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]}]},{"title1":"Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"APACHE II: a severity of disease classification system","References":[]},{"title2":"Accuracy and reliability of APACHE II scoring in two intensive care units problems and pitfalls in the use of APACHE II and suggestions for improvement","References":[]},{"title2":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","References":[]},{"title2":"Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020","References":[{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"The fight against the 2019-nCoV outbreak: an arduous march has just begun"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Better understanding on MERS corona virus outbreak in Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection"},{"title3":"Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults"},{"title3":"Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]}]},{"title1":"Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study","References":[{"title2":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020. 10.1002/jmv.25678.","References":[]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020. 10.1001/jama.2020.0757.","References":[]},{"title2":"WHO. Situation report-55. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_6. Accessed 12 Apr 2020.","References":[]},{"title2":"WHO: Shortage of personal protective equipment endangering health workers worldwide. https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide. Accessed 12 Apr 2020.","References":[]},{"title2":"Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020. 10.1016/S2214-109X(20)30068-1.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. 10.1016/S2213-2600(20)30079-5.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. 10.1001/jama.2020.2648.","References":[]},{"title2":"National Health Commission of the People's Republic of China. Feb 27: daily briefing on novel coronavirus cases in China. http://en.nhc.gov.cn/2020-02/27/c_76975.htm. Accessed 12 Apr 2020.","References":[]},{"title2":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032.","References":[]},{"title2":"Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study","References":[]},{"title2":"Lessons to learn from epidemiologic studies in ARDS","References":[]},{"title2":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. 10.1001/jama.2020.1585.","References":[]},{"title2":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study","References":[]},{"title2":"Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission","References":[{"title3":"Primary immunodeficiency diseases due to defects in lymphocytes"},{"title3":"Infection by human immunodeficiency virus-CD4 is not enough"},{"title3":"The pathophysiology and treatment of sepsis"},{"title3":"Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony"},{"title3":"Sepsis induces early alterations in innate immunity that impact mortality to secondary infection"},{"title3":"Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock"},{"title3":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction"},{"title3":"Decrease in circulating dendritic cells predicts fatal outcome in septic shock"},{"title3":"The delayed hypersensitivity response and host resistance in surgical patients. 20 years later"},{"title3":"Apoptosis and caspases regulate death and inflammation in sepsis"},{"title3":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans"},{"title3":"Early assessment of leukocyte alterations at diagnosis of septic shock"},{"title3":"Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit"},{"title3":"Risk factors in postoperative sepsis: significance of preoperative lymphocytopenia"},{"title3":"Persistent lymphopenia after diagnosis of sepsis predicts mortality"},{"title3":"HELICS: a European project to standardise the surveillance of hospital acquired infection, 1994-1995"},{"title3":"Propensity scores in intensive care and anaesthesiology literature: a systematic review"},{"title3":"What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists"},{"title3":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study"},{"title3":"Downregulation of CD40 ligand response in monocytes from sepsis patients"},{"title3":"Anti-inflammatory cytokine profile and mortality in febrile patients"},{"title3":"Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome"},{"title3":"Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients"},{"title3":"Immunoparalysis as a cause for invasive aspergillosis?"},{"title3":"Cytomegalovirus reactivation in critically ill immunocompetent patients"},{"title3":"A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1"},{"title3":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies"},{"title3":"Immunosuppression in patients who die of sepsis and multiple organ failure"},{"title3":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients"},{"title3":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach"},{"title3":"Decreased T-cell repertoire diversity in sepsis: a preliminary study"},{"title3":"Transient lymphopenia in acutely unwell young infants"},{"title3":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure"},{"title3":"Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma"},{"title3":"Relationships between T lymphocyte apoptosis and anergy following trauma"},{"title3":"Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients"},{"title3":"Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock"},{"title3":"A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis"}]},{"title2":"Association of lymphopenia with short term outcomes of sepsis patients; a brief report","References":[{"title3":"Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis"},{"title3":"Review article: Sepsis in the emergency department - Part 1: Definitions and outcomes"},{"title3":"The effect of fluid therapy on hemodynamic and venous blood gas parameters in patients with septic shock"},{"title3":"Persistent lymphopenia after diagnosis of sepsis predicts mortality"},{"title3":"Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays"},{"title3":"Correlation of Blood Gas Parameters with Central Venous Pressure in Patients with Septic Shock; a Pilot Study"},{"title3":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy"},{"title3":"Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges"},{"title3":"Leukocyte apoptosis and its significance in sepsis and shock"},{"title3":"Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients"},{"title3":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure"},{"title3":"Early assessment of leukocyte alterations at diagnosis of septic shock"},{"title3":"Relation between lymphopenia and bacteraemia in UK adults with medical emergencies"},{"title3":"Lymphopenia Is Associated With Worse Outcome In Patients With Severe Sepsis"},{"title3":"Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naive T-cells but no enduring cell-autonomous defects in T-cell function"},{"title3":"Interleukin-10/lymphocyte ratio predicts mortality in severe septic patients"}]},{"title2":"Li Z, Wu M, Guo J, Yao J, Liao X, Song S, Han M, Li J, Duan G, Zhou Y, Wu X, Zhou Z, Wang T, Hu M, Chen X, Fu Y, Lei C, Dong H, Zhou Y, Jia H, Chen X, Yan J (2020) Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv:2020.2002.2008.20021212. doi:10.1101/2020.02.08.20021212.","References":[]},{"title2":"Critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Chest radiography versus lung ultrasound for identification of acute respiratory distress syndrome: a retrospective observational study","References":[{"title3":"ARDS Definition Task Force, ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526-33."},{"title3":"Outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition"},{"title3":"Accuracy of the chest radiograph to identify bilateral pulmonary infiltrates consistent with the diagnosis of acute respiratory distress syndrome using computed tomography as reference standard"},{"title3":"Lung ultrasound in acute respiratory distress syndrome and beyond"},{"title3":"Review article: use of ultrasound in the developing world"},{"title3":"Accuracy of lung ultrasonography versus chest radiography for the diagnosis of adult community-acquired pneumonia: review of the literature and meta-analysis"},{"title3":"Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: systematic review and meta-analysis"},{"title3":"Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome"},{"title3":"The BLUE-points: three standardized points used in the BLUE-protocol for ultrasound assessment of the lung in acute respiratory failure"},{"title3":"Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients"},{"title3":"Pulmonary ultrasound and pulse oximetry versus chest radiography and arterial blood gas analysis for the diagnosis of acute respiratory distress syndrome: a pilot study"},{"title3":"External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS"},{"title3":"Coudroy R, Frat JP, Boissier F, Contou D, Robert R, Thille AW. Early identification of acute respiratory distress disorder in the absence of positive pressure ventilation: implications for revision of the berlin criteria for acute respiratory distress syndrome. Crit Care Med. 2018;46(4):540-6."},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Lung ultrasound training: curriculum implementation and learning trajectory among respiratory therapists"},{"title3":"International evidence-based recommendations for point-of-care lung ultrasound"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Ultrasound assessment of lung aeration loss during a successful weaning trial predicts postextubation distress"},{"title3":"Interobserver variability in applying a radiographic definition for ARDS"},{"title3":"Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome"},{"title3":"Lung water assessment by lung ultrasonography in intensive care: a pilot study"}]},{"title2":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, Network C-LI. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020. 10.1001/jama.2020.5394.","References":[]},{"title2":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020. 10.1001/jama.2020.4326.","References":[]}]},{"title1":"Analysis of 92 deceased patients with COVID?19","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"  . Home page. http://www.nhc.gov.cn/xcs/yqtb/202004/fa7bb40a7fbf4b2c8f3989d512fe5b77.shtml. Accessed March 10, 2020.","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Guideline for diagnosis and treatment of novel coronavirus-infected pneumonia (Trial version 3)","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","References":[{"title3":"Outbreak of severe acute respiratory syndrome-worldwide"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Adaptation of human enteric coronavirus to growth in cell lines"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"}]},{"title2":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV-Summary of Current Situation"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection"},{"title3":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants"},{"title3":"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus"},{"title3":"ClustalW and ClustalX version 2 (2007)"},{"title3":"MRBAYES: Bayesian inference of phylogenetic trees"},{"title3":"Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus"},{"title3":"Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS"},{"title3":"Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis"},{"title3":"Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected"}]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience","References":[]},{"title2":"Cardiovascular complications of severe acute respiratory syndrome","References":[]},{"title2":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","References":[]},{"title2":"Myocarditis","References":[]},{"title2":"Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)","References":[]},{"title2":"Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues","References":[]},{"title2":"An interferon-gamma-related cytokine storm in SARS patients","References":[{"title3":"The interferons and cell death: Guardians of the cell or accomplices of apoptosis?"},{"title3":"Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death"},{"title3":"Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus"},{"title3":"Transforming growth factor-beta: A mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Pegylated interferon-alpha protects type I pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Dengue hemorrhagic fever in infants: A study on clinical and cytokine profiles"},{"title3":"Induction of interferon-inducible protein-10 and monokine induced by interferon-gamma from human endothelial cells infected with influenza A virus"},{"title3":"Roles of insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: Potential mechanisms for viral-induced insulitis and beta-cell death in type I diabetes mellitus"},{"title3":"Respiratory syncytial virus-induced chemokine production: Linking viral replication to chemokine production in vitro and in vivo"},{"title3":"Inflammatory cytokine profile in children with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes"},{"title3":"Inhibition of SARS Coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: The roles of cytokines and cellular immune activation in patients with pulmonary edema"},{"title3":"Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas"},{"title3":"Plasma inflammatory cytokines and chemokines in severe respiratory syndrome"},{"title3":"Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan"},{"title3":"Early detection of antibodies against various structural proteins of the SARS-associated Coronavirus in SARS patients"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"}]},{"title2":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in Covid-19: key therapeutic targets?","References":[{"title3":"MERS-CoV: understanding the latest human coronavirus threat"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"[A pathological report of three COVID-19 cases by minimally invasive autopsies]"},{"title3":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019"},{"title3":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical and virological data of the first cases of COVID-19 in Europe: a case series"},{"title3":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China"},{"title3":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients"},{"title3":"Human coronavirus: host-pathogen interaction"},{"title3":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis"},{"title3":"Structural insights into coronavirus entry"},{"title3":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade"},{"title3":"Type II transmembrane serine proteases"},{"title3":"Type II transmembrane serine proteases in cancer and viral infections"},{"title3":"Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium"},{"title3":"Influenza virus activating host proteases: identification, localization and inhibitors as potential therapeutics"},{"title3":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection"},{"title3":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium"},{"title3":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium"},{"title3":"SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells"},{"title3":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"COVID-19: gastrointestinal manifestations and potential fecal-oral transmission"},{"title3":"SARS-CoV-2 productively infects human gut enterocytes"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"SARS-associated coronavirus transmitted from human to pig"},{"title3":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2"},{"title3":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice"},{"title3":"The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses"},{"title3":"TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice"},{"title3":"DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice"},{"title3":"RIG-I and Other RNA Sensors in antiviral immunity"},{"title3":"Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus"},{"title3":"Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells"},{"title3":"Respiratory epithelial cells orchestrate pulmonary innate immunity"},{"title3":"SARS coronavirus and innate immunity"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a toll-like-receptor-related TRAF3-independent mechanism"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells"},{"title3":"Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway"},{"title3":"Applications and approaches for 3D precision-cut lung slices: disease modeling and drug discovery"},{"title3":"Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model"},{"title3":"Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices"},{"title3":"Human airway trypsin-like protease increases mucin gene expression in airway epithelial cells"},{"title3":"Influenza A induces the major secreted airway mucin MUC5AC in a protease-EG, FR-extracellular regulated kinase-Sp1-dependent pathway"},{"title3":"TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds"},{"title3":"Silver nanoparticles impair retinoic acid-inducible gene i-mediated mitochondrial antiviral immunity by blocking the autophagic flux in lung epithelial cells"},{"title3":"The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis"},{"title3":"The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro"},{"title3":"Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARgamma"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"Allelic variation in the toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Toll-like receptors in the pathogenesis of human disease"},{"title3":"Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations"},{"title3":"Severe influenza pneumonitis in children with inherited TLR3 deficiency"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome"},{"title3":"Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS"},{"title3":"Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome"},{"title3":"Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure"},{"title3":"Extracellular matrix proteolysis by MT1-MMP contributes to influenza-related tissue damage and mortality"},{"title3":"Influenza a virus pre-infection exacerbates Pseudomonas aeruginosa-mediated lung damage through increased MMP-9 expression, decreased elafin production and tissue resilience"},{"title3":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV"},{"title3":"SOCS proteins in infectious diseases of mammals"},{"title3":"Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway"},{"title3":"Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection"},{"title3":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro"},{"title3":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology"},{"title3":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for Coronavirus Disease 2019 (COVID-19)"},{"title3":"SARS-CoV-2 vaccines: status report"},{"title3":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses"},{"title3":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2"},{"title3":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity"},{"title3":"Trained immunity and local innate immune memory in the lung"},{"title3":"Induction of autonomous memory alveolar macrophages requires t cell help and is critical to trained immunity"},{"title3":"Effects of toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine"},{"title3":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?"},{"title3":"Innate immune memory of tissue-resident macrophages and trained innate immunity: re-vamping vaccine concept and strategies"},{"title3":"Host signaling and proteolytic pathways in the resolution or the exacerbation of coronavirus (CoV-2) infection in COVID-19 disease: what therapeutic targets?"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome","References":[{"title3":"Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome"},{"title3":"Should we stimulate or suppress immune responses in COVID-19?. Cytokine and anti-cytokine interventions"},{"title3":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients"},{"title3":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure"},{"title3":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy"},{"title3":"Clinical and immunological features of severe and moderate coronavirus disease 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"}]},{"title2":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","References":[]},{"title2":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection-clinicopathological and ultrastructural study","References":[{"title3":"Description of a hospital outbreak of Middle East respiratory syndrome in a large tertiary care hospital in Saudi Arabia"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital"},{"title3":" In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Middle East respiratory syndrome coronavirus (MERSCoV): perceptions, predictions, preventions and the pilgrimage"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"A case report of a Middle East respiratory syndrome survivor with kidney biopsy results"},{"title3":"Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"}]},{"title2":"Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study","References":[{"title3":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"Novel coronavirus pneumonia prevention and control program"},{"title3":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT"},{"title3":"Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis"},{"title3":"Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia"}]},{"title2":"Liver injury in COVID-19: management and challenges","References":[{"title3":"The cytokine storm and COVID-19"},{"title3":"Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19 and liver disease"},{"title3":"COVID-19 and the liver"},{"title3":"Liver Dysfunction Is Associated with Long-Term Mortality in Septic Shock"},{"title3":"Review article: COVID-19 and liver disease-what we know on 1st May 2020"},{"title3":"Gastrointestinal and liver manifestations in patients with COVID-19"},{"title3":"Liver diseases in COVID-19: Etiology, treatment and prognosis"},{"title3":"COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies"},{"title3":"Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis"},{"title3":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features"},{"title3":"Clinical characteristics of 82 cases of death from COVID-19"},{"title3":"Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"SARS-CoV-2 Infection in Children"},{"title3":"Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study"},{"title3":"Clinical Features of COVID-19-Related Liver Functional Abnormality"},{"title3":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China"},{"title3":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area"},{"title3":"Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series"},{"title3":"Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China"},{"title3":"Liver tests abnormalities in COVID-19: trick or treat?"},{"title3":"Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic"},{"title3":"Health Status of Patients Who Underwent Liver Transplantation During the Coronavirus Outbreak at a Large Center in Milan, Italy"},{"title3":"COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission"},{"title3":"COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract"},{"title3":"Liver injury in COVID-19: management and challenges"},{"title3":"Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Apoptosis: a mechanism of acute and chronic liver injury"},{"title3":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"COVID-19 in a designated infectious diseases hospital outside Hubei Province, China"},{"title3":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"A literature review for the mechanisms of stress-induced liver injury"},{"title3":"Mechanisms and treatment of organ failure in sepsis"},{"title3":"Liver - guardian, modifier and target of sepsis"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein"},{"title3":"Human neutralizing antibodies elicited by SARS-CoV-2 infection"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects"},{"title3":"A phase I trial of intravenous interleukin-6 in patients with advanced cancer"},{"title3":"Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells"},{"title3":"Systemic inflammation as fuel for acute liver injury in COVID-19"},{"title3":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality"},{"title3":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"Liver injury during highly pathogenic human coronavirus infections"},{"title3":"SARS-CoV-2: a storm is raging"},{"title3":"In the eye of the COVID-19 cytokine storm"},{"title3":"Viral and host factors related to the clinical outcome of COVID-19"},{"title3":"Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)"},{"title3":"Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China"},{"title3":"Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus"},{"title3":"Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells"},{"title3":"Adipokines: molecular links between obesity and atheroslcerosis"},{"title3":"A new perspective on C-reactive protein in H7N9 infections"},{"title3":"C-reactive protein as a biomarker of severe H1N1 influenza"},{"title3":"Cognitive decline in Parkinson disease"},{"title3":"Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019"},{"title3":"Effect of Gastrointestinal Symptoms in Patients With COVID-19"},{"title3":"Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study"},{"title3":"AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19"},{"title3":"Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study"},{"title3":"Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)"},{"title3":"COVID-19 and liver injury: where do we stand?"},{"title3":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection"},{"title3":"Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China"},{"title3":"Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement"},{"title3":"COVID-19: Abnormal liver function tests"},{"title3":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19"},{"title3":"Hepatic manifestations of COVID-19"},{"title3":"Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies"},{"title3":"Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis"},{"title3":"Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease"},{"title3":"Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study"},{"title3":"Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19"},{"title3":"Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study"},{"title3":"Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations"},{"title3":"Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study"},{"title3":"COVID-19 in solid organ transplant recipients: A single-center case series from Spain"},{"title3":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter"},{"title3":"COVID-19 in solid organ transplantation patients: A systematic review"},{"title3":"Tocilizumab and liver injury in patients with COVID-19"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor"},{"title3":"A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?"},{"title3":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir"},{"title3":"Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study"},{"title3":"Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives"},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design"},{"title3":"Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms"},{"title3":"Remdesivir for the Treatment of Covid-19 - Final Report"},{"title3":"Remdesivir for 5 or 10 Days in Patients with Severe Covid-19"},{"title3":"Liver injury in remdesivir-treated COVID-19 patients"},{"title3":"Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019"},{"title3":"Etiology and management of liver injury in patients with COVID-19"},{"title3":"Therapeutic Potential for Tetracyclines in the Treatment of COVID-19"},{"title3":"Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study"},{"title3":"Azithromycin augments rhinovirus-induced IFNbeta via cytosolic MDA5 in experimental models of asthma exacerbation"},{"title3":"Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 Levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis"},{"title3":"Azithromycin for COVID-19: More Than Just an Antimicrobial?"},{"title3":"Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective"},{"title3":"Off-label use of tocilizumab in patients with SARS-CoV-2 infection"},{"title3":"First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19"},{"title3":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics"},{"title3":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine"},{"title3":"Liver Injury in COVID-19: Caution and Management"},{"title3":"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review"},{"title3":"Tocilizumab and COVID-19"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report"},{"title3":"Polygalasaponin F treats mice with pneumonia induced by influenza virus"},{"title3":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study"},{"title3":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro"},{"title3":"The dual protease inhibitor lopinavir/ritonavir (LPV/r) exerts genotoxic stress on lung cells"},{"title3":"Ritonavir and Lopinavir Suppress RCE1 and CAAX Rab Proteins Sensitizing the Liver to Organelle Stress and Injury"},{"title3":"Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature"},{"title3":"Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in mice"},{"title3":"Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Current pharmacological treatments for COVID-19: What's next?"},{"title3":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity"},{"title3":"COVID-19: A review of the proposed pharmacological treatments"},{"title3":"Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis"},{"title3":"Chloroquine attenuates paraquat-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis"},{"title3":"Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055"},{"title3":"The gut microbiota and host health: a new clinical frontier"},{"title3":"Contributions of the intestinal microbiome in lung immunity"},{"title3":"Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19"},{"title3":"Assessment of Renal and Hepatic Tissue-Protective Effects of N-Acetylcysteine via Ammonia Metabolism: A Prospective Randomized Study"},{"title3":"Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?"},{"title3":"Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke"},{"title3":"Could Vitamins Help in the Fight Against COVID-19?"},{"title3":"Role of vitamin E in nonalcoholic fatty liver disease"},{"title3":"Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths"},{"title3":"Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies"},{"title3":"Potential protection of vitamin C against liver-lesioned mice"},{"title3":"Zinc and COVID-19: Basis of Current Clinical Trials"},{"title3":"Zinc and liver disease"},{"title3":"Possibility of magnesium supplementation for supportive treatment in patients with COVID-19"},{"title3":"Magnesium and liver disease"},{"title3":"COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2"},{"title3":"Is copper beneficial for COVID-19 patients?"},{"title3":"Dose-related effects of dexamethasone on liver damage due to bile duct ligation in rats"},{"title3":"Corticosteroids in Acute Lung Injury: The Dilemma Continues"}]},{"title2":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","References":[]},{"title2":"Renal ACE2 expression in human kidney disease","References":[]},{"title2":"ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection","References":[]},{"title2":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","References":[{"title3":"Offline: 2019-nCoV outbreak:early lessons"},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020; 10.1016/S0140-6736(20)30183-5."},{"title3":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 10.1016/S0140-6736(20)30211-7."},{"title3":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 10.1056/NEJMoa2001191."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020:1-4."},{"title3":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 10.1016/S0140-6736(20)30251-8."},{"title3":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020:1-4."},{"title3":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020; 10.1101/2020.01.26.919985."},{"title3":"The genotype-tissue expression (GTEx) project"},{"title3":"A gene expression signature that correlates with CD8+ T cell expansion in acute EBV infection"},{"title3":"Molecular and genetic properties of tumors associated with local immune cytolytic activity"},{"title3":"Controlling the false discovery rate: a practical and powerful approach to multiple testing"},{"title3":"Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Case fatality of SARS in mainland China and associated risk factors"},{"title3":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020; 10.1002/jmv.25685."},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"}]}]},{"title1":"Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis","References":[{"title2":"Ace2: from vasopeptidase to SARS virus receptor","References":[{"title3":"The angiotensin-converting enzyme gene family: genomics and pharmacology"},{"title3":"ACE revisited: a new target for structure-based drug design"},{"title3":"A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Increased angiotensin-(1-7)-forming activity in failing human heart ventricles. Evidence for up-regulation of the angiotensin-converting enzyme homologue ACE2"},{"title3":"Cardiac angiotensin-(1-7) in ischemic cardiomyopathy"},{"title3":"Counterregulatory actions of angiotensin-(1-7)"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins"},{"title3":"Two single nucleotide polymorphisms in the ACE2 locus are associated with cardiovascular disease"},{"title3":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy"},{"title3":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors"},{"title3":"Novel peptide inhibitors of angiotensin-converting enzyme 2"},{"title3":"Angiotensin-converting enzyme-2 (ACE2): Comparative modeling of the active site, specificity requirements, and chloride dependence"},{"title3":"Crystal structure of the human angiotensin-converting enzyme-lisinopril complex"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"A model of the ACE2 structure and function as a SARS-CoV receptor"},{"title3":"Towler, P. et al. ACE2 structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. (in press)."},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy"},{"title3":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase"},{"title3":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus"},{"title3":"The interaction of animal cytoplasmic RNA viruses with the nucleus to facilitate replication"}]},{"title2":"Cardiovascular complications of severe acute respiratory syndrome","References":[]},{"title2":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"National Health Commission of the People's Republic of China. Novel Coronavirus-Pneumonia diagnostic and treatment regimens","References":[]},{"title2":"Pneumonia as a cardiovascular disease: Pneumonia-related cardiac damage","References":[]},{"title2":"[Study on the myocardiac injury in patients with severe acute respiratory syndrome]","References":[]},{"title2":"Acute myocarditis associated with novel middle East respiratory syndrome coronavirus","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis"},{"title3":"Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology"},{"title3":"Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches"},{"title3":"Cardiovascular magnetic resonance in myocarditis: A JACC White Paper"},{"title3":"Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction"},{"title3":"First epidemiological results"},{"title3":"Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates"},{"title3":"Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy"},{"title3":"Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence"},{"title3":"Long term follow up of acute myocarditis. Correlation of ventricular function and outcome"},{"title3":"A clinical trial of immunosuppressive therapy for myocarditis"}]},{"title2":"Transient cardiac injury during H7N9 infection","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic Society and infectious diseases Society of America","References":[{"title3":"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"},{"title3":"GRADE guidelines: 2. Framing the question and deciding on important outcomes"},{"title3":"Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination"},{"title3":"Usefulness of sputum Gram staining in community-acquired pneumonia [in Japanese]"},{"title3":"Does sputum culture affect the management and/or outcome of community-acquired pneumonia?"},{"title3":"Sputum examination in the clinical management of community-acquired pneumonia [in Portuguese]"},{"title3":"Impact of guideline-concordant microbiological testing on outcomes of pneumonia"},{"title3":"Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia"},{"title3":"Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia"},{"title3":"Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study"},{"title3":"Factors associated with unknown aetiology in patients with community-acquired pneumonia"},{"title3":"Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions"},{"title3":"Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system"},{"title3":"Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations"},{"title3":"Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization"},{"title3":"Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization"},{"title3":"Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia"},{"title3":"Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia"},{"title3":"Use of tracheal aspirate culture in newly intubated patients with community-onset pneumonia"},{"title3":"Quality of care, process, and outcomes in elderly patients with pneumonia"},{"title3":"Selective use of blood cultures in emergency department pneumonia patients"},{"title3":"Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals"},{"title3":"The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study"},{"title3":"The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures"},{"title3":"The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia"},{"title3":"Predicting bacteremia in patients with community-acquired pneumonia"},{"title3":"Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality"},{"title3":"Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia"},{"title3":"The routine use of urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment"},{"title3":"Vital signs: deficiencies in environmental control identified in outbreaks of legionnaires' disease. North America, 2000-2014"},{"title3":"Active bacterial core surveillance for legionellosis: United States, 2011-2013"},{"title3":"Preventing and controlling influenza with available interventions"},{"title3":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa"},{"title3":"Community-acquired pneumonia"},{"title3":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial"},{"title3":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections"},{"title3":"Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia"},{"title3":"Low procalcitonin, community acquired pneumonia, and antibiotic therapy"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia"},{"title3":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia"},{"title3":"Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial"},{"title3":"Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients"},{"title3":"Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial"},{"title3":"The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia"},{"title3":"Improved management of community-acquired pneumonia in the emergency department"},{"title3":"Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study"},{"title3":"Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial"},{"title3":"Low-risk patients admitted with community-acquired pneumonia"},{"title3":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia"},{"title3":"Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial"},{"title3":"Treatment costs of community-acquired pneumonia in an employed population"},{"title3":"Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population"},{"title3":"CURB-65 pneumonia severity assessment adapted for electronic decision support"},{"title3":"Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission"},{"title3":"Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia"},{"title3":"Validation of the Infectious Diseases Society of America/American Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care"},{"title3":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},{"title3":"Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia"},{"title3":"Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis"},{"title3":"Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia"},{"title3":"The impact of a delay in intensive care unit admission for community-acquired pneumonia"},{"title3":"Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia"},{"title3":"Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality"},{"title3":"Antibiotics for community-acquired pneumonia in adolescent and adult outpatients"},{"title3":"Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies"},{"title3":"Efficacy and safety of moxifloxacin vs clarithromycin for community-acquired pneumonia"},{"title3":"A comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study"},{"title3":"A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia"},{"title3":"Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia"},{"title3":"Clinical evaluation of telithromycin for community-acquired pneumonia phase III double-blind comparative study of telithromycin versus levofloxacin"},{"title3":"A randomized, double-blind, multicenter phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia"},{"title3":"Comparison of clarithromycin and amoxicillin/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae"},{"title3":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults"},{"title3":"Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia"},{"title3":"Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia"},{"title3":"Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia"},{"title3":"Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia"},{"title3":"Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults"},{"title3":"Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia"},{"title3":"Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime"},{"title3":"Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis"},{"title3":"Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults"},{"title3":"Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults"},{"title3":"Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia"},{"title3":"Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae"},{"title3":"Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days"},{"title3":"Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia"},{"title3":"Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia"},{"title3":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae"},{"title3":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management"},{"title3":"Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults"},{"title3":"A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia"},{"title3":"High-dose levofloxacin in community-acquired pneumonia: a randomized, open-label study"},{"title3":"An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia"},{"title3":"Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors"},{"title3":"Antibiotic treatment strategies for community-acquired pneumonia in adults"},{"title3":"Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia"},{"title3":"Fluoroquinolones or macrolides alone versus combined with beta-lactams for adults with community-acquired pneumonia: systematic review and meta-analysis"},{"title3":"Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review"},{"title3":"Omadacycline for community-acquired bacterial pneumonia"},{"title3":"beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial"},{"title3":"beta-Lactam/macrolide dual therapy versus beta-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis"},{"title3":"Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Efficacy and safety of iv-to-oral lefamulin, a pleuromutilin antibiotic, for treatment of community-acquired bacterial pneumonia: the phase 3 LEAP 1 trial"},{"title3":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Fluoroquinolones or macrolides in combination with beta-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Quantitative aspiration during sleep in normal subjects"},{"title3":"Aspiration pneumonitis and aspiration pneumonia"},{"title3":"Nursing home-acquired pneumonia: a case-control study"},{"title3":"A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia"},{"title3":"Treatment of aspiration pneumonia and primary lung abscess: penicillin G vs clindamycin"},{"title3":"Bacteriologic flora of aspiration-induced pulmonary infections"},{"title3":"Microbiology of severe aspiration pneumonia in institutionalized elderly"},{"title3":"The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study"},{"title3":"Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures"},{"title3":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia"},{"title3":"Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia"},{"title3":"Health care-associated pneumonia in the intensive care unit: guideline-concordant antibiotics and outcomes"},{"title3":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia"},{"title3":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis"},{"title3":"Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home"},{"title3":"Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?"},{"title3":"Adding fuel to the flames? It is time to leave HCAP"},{"title3":"Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia"},{"title3":"Trends in antibiotic use and nosocomial pathogens in hospitalized Veterans with pneumonia at 128 medical centers, 2006-2010"},{"title3":"Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia"},{"title3":"Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia"},{"title3":"Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model"},{"title3":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score"},{"title3":"Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis"},{"title3":"Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa"},{"title3":"Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia"},{"title3":"Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia"},{"title3":"Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital"},{"title3":"Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia"},{"title3":"Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia"},{"title3":"Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment"},{"title3":"Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease"},{"title3":"Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients"},{"title3":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia"},{"title3":"The respiratory threat posed by multidrug resistant Gram-negative bacteria"},{"title3":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia"},{"title3":"A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia"},{"title3":"Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study"},{"title3":"Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors"},{"title3":"Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens"},{"title3":"Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia"},{"title3":"Liver cirrhosis and diabetes mellitus are risk factors for Staphylococcus aureus infection in patients with healthcare-associated or hospital-acquired pneumonia"},{"title3":"Global initiative for methicillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study"},{"title3":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients"},{"title3":"De-escalation therapy among bacteraemic patients with community-acquired pneumonia"},{"title3":"Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia"},{"title3":"Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia"},{"title3":"De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia"},{"title3":"Broad- versus narrow-spectrum oral antibiotic transition and outcomes in health care-associated pneumonia"},{"title3":"De-escalation as part of a global strategy of empiric antibiotherapy management: a retrospective study in a medico-surgical intensive care unit"},{"title3":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial"},{"title3":"Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis"},{"title3":"Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US Veterans Affairs Medical Centers"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia"},{"title3":"The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications"},{"title3":"Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study"},{"title3":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia"},{"title3":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update"},{"title3":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza"},{"title3":"Outcomes of adults hospitalised with severe influenza"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"},{"title3":"Fatalities associated with the 2009 H1N1 influenza A virus in New York city"},{"title3":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials"},{"title3":"Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis"},{"title3":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza"},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States"},{"title3":"Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season"},{"title3":"Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza"},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection"},{"title3":"Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis"},{"title3":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study"},{"title3":"Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study"},{"title3":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm"},{"title3":"Efficacite comparee de la ceftriaxone dans un traitement de dix jours versus un traitement raccourci de cinq jours des pneumonies aigues communautaires de l'adulte hospitalise avec facteur de risque [in French]"},{"title3":"Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis"},{"title3":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis"},{"title3":"Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults"},{"title3":"Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ"},{"title3":"Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis"},{"title3":"Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection"},{"title3":"Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines"},{"title3":"Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin"},{"title3":"Predictors and implications of early clinical stability in patients hospitalized for moderately severe community-acquired pneumonia"},{"title3":"Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome"},{"title3":"Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients"},{"title3":"Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications"},{"title3":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial"},{"title3":"Is post-pneumonia chest X-ray for lung malignancy useful? Results of an audit of current practice"},{"title3":"Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up"},{"title3":"Outcome of recommendations for radiographic follow-up of pneumonia on outpatient chest radiography"},{"title3":"Incidence, correlates, and chest radiographic yield of new lung cancer diagnosis in 3398 patients with pneumonia"},{"title3":"Diagnosis of pulmonary malignancy after hospitalization for pneumonia"},{"title3":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement"}]},{"title2":"Prevalence of comorbidities in the middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","References":[]},{"title2":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","References":[]},{"title2":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report - 44"},{"title3":"Which lessons shall we learn from the 2019 novel coronavirus outbreak?"},{"title3":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Estimating the mean and variance from the median, range, and the size of a sample"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Laboratory abnormalities in patients with COVID-2019 infection"}]}]}]}